As of Oct 2, 2026 close
- Assets (AUM)
- $424.35M
- Expense ratio
- 0.59%
- Dividend yield
- 1.38%
- Holdings
- 33
- 52-week range
- $70.01$98.82
- Volume (live)
- —
- Avg. volume (3M)
- 18.70K
PBE ETF: Invesco Biotechnology & Genome ETF - Price, Holdings & Analysis
Invesco Biotechnology & Genome ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $94.62 - $95.58 |
|---|---|
| 52-Week High | $98.82 |
| 52-Week Low | $70.01 |
| Open | $95.58 |
| Volume (last close) | 18.13K |
| Average Volume (3M) | 18.70K |
| Assets (AUM) | 424.35M |
|---|---|
| Expense Ratio | 0.59% |
| Total Holdings | 33 |
| Inception Date | Jun 22, 2005 |
| 1 Day Change | −0.03% |
|---|---|
| 1 Month Change | −2.63% |
| 6 Month Change | +20.55% |
| YTD Change | +15.45% |
| 1 Year Change | +30.76% |
| 52-Week Change | +32.02% |
| 5 Year Change | +28.80% |
| 10 Year Change | +123.75% |
| 50-Day MA | $94.85 |
|---|---|
| 200-Day MA | $85.70 |
| RSI | 47.05 |
| Stochastic %K | 45.54 |
| Stochastic %D | 59.47 |
| Annual Dividend | $1.31 |
|---|---|
| Dividend Yield | 1.38% |
| Last Dividend Ex-Date | Jun 22, 2026 |
| Dividend Growth YoY | 229.90% |
| Years Dividend Growth | 2 |
PBE at a Glance
Invesco Biotechnology & Genome ETF (PBE) is an equity ETF from Invesco, launched in June 2005. It manages $424.35M in assets and charges a 0.59% expense ratio, about $59 a year per $10,000 invested.
It holds 33 positions. The largest are Natera, Inc. (NTRA, 6.31%), Illumina, Inc. (ILMN, 6.29%) and Biogen Inc (BIIB, 5.18%). The top 10 holdings make up 49.2% of the fund. By sector it leans toward Healthcare (100.0%). 100.0% of assets are in the United States.
It pays distributions yielding 1.38%, $1.31 per share over the last year. The share price is up 30.8% over one year, up 28.8% over five years and up 123.7% over ten years (price change, excluding distributions).
Frequently Asked Questions About Invesco Biotechnology & Genome ETF
What is the current price of PBE?
The latest PBE price is $95.07 (Oct 2, 2026 close). The 52-week range is $70.01–$98.82. PBE has returned 32.0% over the past 52 weeks.
What is the expense ratio for PBE?
PBE's annual expense ratio is 0.59%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does PBE pay dividends?
Yes, PBE pays a 1.38% dividend yield. The last ex-dividend date was 2026-06-22. View full dividend history in the Dividends section.
What are the top holdings of PBE?
PBE's largest holdings are Natera, Inc. (6.3%), Illumina, Inc. (6.3%), Biogen Inc (5.2%) (combined weight: 17.8%). The fund holds 33 total positions. View the complete portfolio breakdown in the Holdings section.
How does PBE compare to similar ETFs?
Compare PBE (0.59% expense ratio, $424M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.